GAUGING THE SAFETY AND EFFICACY OF NITROGLYCERINE USED TRANSDERMALLY AS A TOCOLYTIC AGENT IN FEMALES WITH PRETERM LABOR

Abstract

Background: Preterm delivery is a persistent difficulty for obstetricians and has been a prevalent worry with
rising frequency internationally. Approximately 8–10% of births are complicated by preterm birth. Preterm
delivery has a significant related burden and its aetiology is yet unclear.
Aim: The purpose of this study is to evaluate the safety and effectiveness of transdermal nitroglycerine as a
tocolytic drug in pregnant women.
Methods: Two hundred women experiencing premature labour were evaluated for this prospective clinical trial.
These 200 female individuals were split into two groups of 100 each, and each group was randomly assigned to
either bed rest alone or nitroglycerine patch. Six months were spent doing the study.